Tetanus is a life-threatening disease caused by toxins produced by Clostridium tetani, with an estimated global maternal and neonatal mortality of 309,000 and a case fatality rate of 35%. Women of reproductive age are recommended to receive consecutive doses of tetanus toxoid (TT) vaccine to ensure long-term protection. Complete TT immunization provides protective immunity lasting 10 to 30 years, whereas incomplete vaccination leaves individuals vulnerable, particularly after tetanus-prone injuries. Despite the proven effectiveness of TT, financial constraints often limit vaccine access, necessitating donor support to enhance immunization coverage. Ensuring full adherence to the TT schedule is crucial for preventing maternal and neonatal tetanus and protecting against tetanus following injuries sustained in daily activities or specialized settings such as military training. Strengthening awareness and uptake of TT vaccination remains an essential public health strategy to reduce tetanus-related morbidity and mortality among women of reproductive age